BlinkLab Limited (ASX:BB1)

Market Cap	103.95M +161.5%
Revenue (ttm)	375.82K +92.9%
Net Income	-7.24M
EPS	-0.07
Shares Out	152.87M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	132,493
Open	0.7000
Previous Close	0.7000
Day's Range	0.6800 - 0.7000
52-Week Range	0.3450 - 1.1050
Beta	1.31
Analysts	Buy
Price Target	2.01 (+195.59%)
Earnings Date	Jun 1, 2026

About BlinkLab

BlinkLab Limited focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing. Its smartphone-based application serves as a device for conducting neurobehavioral evaluations. The company’s application also enables remote and rapid testing to aid research on neurodevelopmental and neurodegenerative conditions such as schizophrenia, autism, attention deficit hyperactivity disorder (ADHD), and various forms of dementia. The company was incorporated in 2021 and is based in Perth, Australia.

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2021
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: BB1

Financial Performance

In fiscal year 2025, BlinkLab's revenue was 375,551, an increase of 916.07% compared to the previous year's 36,961. Losses were -5.71 million, 225.5% more than in 2024.